Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors Mangala HegdeManjunath B. Joshi Review – Cancer Research Open access 18 February 2021 Pages: 937 - 971
Molecular targeted treatment and drug delivery system for gastric cancer Lanxin JiangXiaomin GongRunwei Yan Review – Cancer Research 07 February 2021 Pages: 973 - 986
Multiple functions of p21 in cancer radiotherapy Yanbei KuangJian KangQiang Li Review – Cancer Research 05 February 2021 Pages: 987 - 1006
Human TERT promoter mutations as a prognostic biomarker in glioma Branka PowterSarah A. JeffreysTherese M. Becker Review – Cancer Research Open access 06 February 2021 Pages: 1007 - 1017
Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma Sannia SjöstedtAne Yde SchmidtChristian von Buchwald Original Article – Cancer Research 13 October 2020 Pages: 1019 - 1027
Correction to: Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma Sannia SjöstedtAne Yde SchmidtChristian von Buchwald Correction 08 December 2020 Pages: 1029 - 1029
GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapy Patrick Sven PlumHeike LöserAlexander Quaas Original Article – Cancer Research Open access 10 December 2020 Pages: 1031 - 1040
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort S. ThijssenH. WildiersP. Neven Original Article – Cancer Research 20 January 2021 Pages: 1041 - 1048
Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment Tongtong WeiJinjing SongJie Yang Original Article – Cancer Research 02 January 2021 Pages: 1049 - 1064
A new monoclonal antibody that blocks dimerisation and inhibits c-kit mutation-driven tumour growth Chenguang BaiYi XuCen Qiu Original Article – Cancer Research Open access 03 January 2021 Pages: 1065 - 1075
Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies Qianyi WanRui ZhaoXiao-Ting Wu Original Article – Cancer Research 12 January 2021 Pages: 1077 - 1087
Evaluation of the morphological features and unfavorable prognostic impact of dirty necrosis in renal cell carcinoma Takashi KuroeReiko WatanabeGenichiro Ishii Original Article – Cancer Research 21 January 2021 Pages: 1089 - 1100
Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells Mengmeng YangZongyu LiZhihao Wu Original Article – Cancer Research Open access 20 January 2021 Pages: 1101 - 1113
Investigation of a novel brachytherapy ureteral stent: trial studies on normal beagle dogs Dechao JiaoYuan YaoJianzhuang Ren Original Article – Cancer Research 25 January 2021 Pages: 1115 - 1123
TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features Sang Kyum KimJang-Hee KimJi Eun Kwon Original Article – Cancer Research Open access 26 February 2021 Pages: 1125 - 1135
Diagnostic and management challenges for MDM2-, CDK4-negative fatty tumors of the retroperitoneum Max L. SilversteinAlexandra N. KalofJessica A. Cintolo-Gonzalez Review – Clinical Oncology 06 February 2021 Pages: 1137 - 1144
Colorectal cancer under 20 years old: a retrospective analysis from three tertiary hospitals Chengjing ZhouWeiwei XiaoYuanhong Gao Original Article – Clinical Oncology Open access 23 September 2020 Pages: 1145 - 1155
Health-related quality of life after Gamma Knife radiosurgery in patients with 1–10 brain metastases Eline VerhaakWietske C. M. SchimmelMargriet M. Sitskoorn Original Article – Clinical Oncology Open access 06 October 2020 Pages: 1157 - 1167
Epidermal growth factor receptor mutations in lung adenocarcinoma: associations between dual-energy spectral CT measurements and histologic results Guojin ZhangYuntai CaoJunlin Zhou Original Article – Clinical Oncology 26 September 2020 Pages: 1169 - 1178
Clinical outcomes in elderly rectal cancer patients treated with neoadjuvant chemoradiotherapy: impact of tumor regression grade Consuelo RosaMonica Di TommasoDomenico Genovesi Original Article – Clinical Oncology 07 October 2020 Pages: 1179 - 1188
Retrospective analysis of data from 73 patients with childhood acute promyelocytic leukaemia receiving modified chemotherapy: a single-centre study Zhi-xiao ZhangAi-dong LuJiong Qin Original Article – Clinical Oncology 02 October 2020 Pages: 1189 - 1201
Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients Karin JasekMarian GrendarZora Lasabova Original Article – Clinical Oncology 12 October 2020 Pages: 1203 - 1215
Does androgen-deprivation therapy increase the risk of ischemic cardiovascular and cerebrovascular diseases in patients with prostate cancer? A nationwide population-based cohort study Do Kyung KimHye Sun LeeKang Su Cho Original Article – Clinical Oncology 30 September 2020 Pages: 1217 - 1226
Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer Tetsuya SakaiHibiki UdagawaGenichiro Ishii Original Article – Clinical Oncology 30 September 2020 Pages: 1227 - 1237
Clinical, social, and psycho-oncological needs of adolescents and young adults (AYA) versus older patients following hematopoietic stem cell transplantation Kristin PulewkaBernhard StraussInken Hilgendorf Original Article – Clinical Oncology Open access 14 October 2020 Pages: 1239 - 1246
An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multi-center study Congkuan SongZhe DongWeidong Hu Original Article – Clinical Oncology 11 October 2020 Pages: 1247 - 1257
The role of clinical factors and immunocheckpoint molecules in the prognosis of patients with supratentorial extraventricular ependymoma: a single-center retrospective study Liguo WangSong HanZuocheng Yang Original Article – Clinical Oncology Open access 02 January 2021 Pages: 1259 - 1270
Re: Results of a randomized trial of treatment modalities in patients with low or early‑intermediate risk prostate cancer (PREFERE trial) Andreas BoehleFrank KahmannStefan Machtens Letter to the Editor Open access 28 January 2021 Pages: 1271 - 1272
Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten’s to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) Thomas WiegelPeter AlbersMichael Stöckle Letter to the Editor Open access 24 February 2021 Pages: 1273 - 1274